Phenazopyridine Hydrochloride

盐酸非那吡啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePhenazopyridine Hydrochloride
Drug Alias NamePhenazopyridinium chloride非那吡啶Phenylazo tablets非那吡啶盐酸盐phenazopyridinum +[22] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsDysuriaPainPain, Postoperative +[5] 
Global Approved IndicationsPain
Approved Indications in ChinaPain
Original Approved Country/TerritoryUnited States
Original Approved Date1928/01/01
Country/TerritoryCanadaUnited StatesTaiwan +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesKaren Pharmaceutical Company Ltd
Inactive CompaniesPhytohealth CoLaboratorios Osorio De Moraes LtdaUniversity Of Massachusetts Medical School +[4] 
Active IndicationsPain
Inactive IndicationsDysuriaPain, PostoperativeUrinary Retention +[4] 

Other Information

ATC CodeG04BX06
Related LinksWikipediaDrugBankKEGG